Evidence map›Paper›PMID 42424290›Full record

ArticleRevista peruana de medicina experimental y salud publica2026

Viral co-infection with SARS-CoV-2 in hospitalized Peruvian patients during 2020-2021.

Carlos Augusto Yabar, Karolyn Vega-Chozo, Eduardo Miranda-Ulloa, Flor de María Peceros-Pelaez, Manuel Terrazas-Aranibar, Adolfo Marcelo, María Paquita García, María Elena López, Rubén Vásquez, Katia Zúñiga and 4 more

Abstract read
In one paragraph

Article in Revista peruana de medicina experimental y salud publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carlos Augusto YabarInnovation and Diagnostic Support Unit, National Institute of Health, Lima, Peru.
Karolyn Vega-ChozoFaculty of Natural and Mathematical Sciences, Universidad Nacional Federico Villarreal, Lima, Peru.
Eduardo Miranda-UlloaNational Reference Laboratory for Sexually Transmitted Viruses, National Institute of Health, Lima, Peru.
Flor de María Peceros-PelaezNational Reference Laboratory for Sexually Transmitted Viruses, National Institute of Health, Lima, Peru.
Manuel Terrazas-AranibarNational Reference Laboratory for Sexually Transmitted Viruses, National Institute of Health, Lima, Peru.
Adolfo MarceloNational Reference Laboratory for Vector-borne and Viral Zoonotic Diseases, National Institute of Health, Lima, Peru.
María Paquita GarcíaNational Reference Laboratory for Vector-borne and Viral Zoonotic Diseases, National Institute of Health, Lima, Peru.
María Elena LópezMaría Auxiliadora Hospital, Lima, Peru.
Rubén VásquezMaría Auxiliadora Hospital, Lima, Peru.
Katia ZúñigaMaría Auxiliadora Hospital, Lima, Peru.
Haydee AlvaradoRegional Hospital of Loreto, Loreto, Peru.
Renso López-LiñánRegional Hospital of Loreto, Loreto, Peru.
Heriberto ArévaloRegional Public Health Reference Laboratory of San Martin, San Martin, Peru.
Nancy Rojas-SerranoNational Reference Laboratory for Vaccine-Preventable Diseases, National Institute of Health, Lima, Peru.

Funding

National Institute of Health of Peru. OC-022-20
6 · The paper itself

Abstract

The study aimed to identify coinfections of SARS-CoV-2 with other viruses in patients with moderate and severe COVID-19. 98 patients from Lima, San Martín, and Loreto were selected, from whom nasopharyngeal secretion, blood, and urine samples were taken and analyzed using serological and molecular tests to detect HTLV, HIV, hepatitis B, dengue, Chikungunya, Zika, and a panel of respiratory viruses (influenza A/B, rhinovirus, respiratory syncytial virus, metapneumovirus, and adenovirus). The results showed two cases of coinfection (2/98; 2%): one with SARS-CoV-2/rhinovirus and another with SARS-CoV-2/HTLV-2. Both patients presented with COVID-19-associated pneumonia but progressed favorably. It is concluded that the frequency of viral coinfection in patients from health facilities in the Peruvian coast and jungle with moderate and severe cases of COVID-19 was low.

Indexed as

CoinfectionCOVID-19Virus DiseasesAdultFemaleHospitalizationHumansMaleMiddle AgedPeruSeverity of Illness IndexLaboratory diagnosisSARS-CoV-2 InfectionSevere Acute Respiratory SyndromeViral Coinfection

Identifiers

PMID42424290
PMCPMC13245989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.